Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Merck
MRK
|
$446M |
| 2 |
Lam Research
LRCX
|
$435M |
| 3 |
NVIDIA
NVDA
|
$375M |
| 4 |
Apple
AAPL
|
$319M |
| 5 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$317M |
Top Sells
| 1 |
SWN
Southwestern Energy Company
SWN
|
$381M |
| 2 |
Exxon Mobil
XOM
|
$324M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
$223M |
| 4 |
SoFi Technologies
SOFI
|
$160M |
| 5 |
VSTO
Vista Outdoor Inc.
VSTO
|
$136M |
Sector Composition
| 1 | Technology | 20.48% |
| 2 | Financials | 18.31% |
| 3 | Industrials | 12.31% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
ALX Oncology
ALXO
$55.2M
| $43.8K | ﹤0.01% |
26,233
-11,413
| -30% | -$19.1K |
|
3302
Drilling Tools International
DTI
$67.4M
| $43.1K | ﹤0.01% |
+13,224
| New | +$43.1K |
|
3303
PharmaCyte Biotech
PMCB
$6.39M
| $41.6K | ﹤0.01% |
26,841
-760
| -3% | -$1.18K |
|
|
CGC
3304
Canopy Growth
CGC
$357M
| $41.4K | ﹤0.01% |
+15,099
| New | +$41.4K |
|
3305
IRIDEX
IRIX
$22.6M
| $41.1K | ﹤0.01% |
24,438
| – | – |
|
3306
Battalion Oil
BATL
$19.3M
| $40.7K | ﹤0.01% |
23,560
| – | – |
|
3307
Dominari Holdings
DOMH
$87.9M
| $39.7K | ﹤0.01% |
39,833
| – | – |
|
3308
Beam Global
BEEM
$47.8M
| $39.2K | ﹤0.01% |
+12,376
| New | +$39.2K |
|
3309
Educational Development Corp
EDUC
$9.7M
| $37.5K | ﹤0.01% |
22,753
+1,889
| +9% | +$3.12K |
|
3310
Arts-Way Manufacturing Co
ARTW
$18.1M
| $36.4K | ﹤0.01% |
16,797
-4,255
| -20% | -$9.23K |
|
3311
Cambium Networks
CMBM
$19.2M
| $35.1K | ﹤0.01% |
54,167
-61,160
| -53% | -$39.6K |
|
3312
Forian
FORA
$65.6M
| $32.1K | ﹤0.01% |
15,592
+550
| +4% | +$1.13K |
|
3313
Carver Bancorp
CARV
$11.8M
| $31.7K | ﹤0.01% |
17,408
| – | – |
|
3314
Cocrystal Pharma
COCP
$15.4M
| $30.3K | ﹤0.01% |
15,015
+923
| +7% | +$1.86K |
|
3315
PDS Biotechnology
PDSB
$58.3M
| $30K | ﹤0.01% |
18,390
-6,908
| -27% | -$11.3K |
|
3316
Sphere 3D
ANY
$17.3M
| $29.9K | ﹤0.01% |
31,639
-41,621
| -57% | -$39.3K |
|
|
KLRS
3317
Kalaris Therapeutics, Inc. Common Stock
KLRS
$74.8M
| $29.5K | ﹤0.01% |
69,769
| – | – |
|
3318
Immuneering
IMRX
$255M
| $29.4K | ﹤0.01% |
13,366
| – | – |
|
3319
ReWalk Robotics
LFWD
$9.7M
| $29.3K | ﹤0.01% |
16,959
-2,048
| -11% | -$3.54K |
|
|
LGO
3320
Largo
LGO
$94.9M
| $29K | ﹤0.01% |
16,872
| – | – |
|
3321
Immunic
IMUX
$78.8M
| $27.5K | ﹤0.01% |
27,521
| – | – |
|
3322
Century Therapeutics
IPSC
$41.1M
| $27.1K | ﹤0.01% |
26,874
-6,575
| -20% | -$6.63K |
|
|
TMQ
3323
Trilogy Metals
TMQ
$266M
| $25.2K | ﹤0.01% |
21,693
| – | – |
|
|
AFMD
3324
DELISTED
Affimed
AFMD
| $21.6K | ﹤0.01% |
18,120
| – | – |
|
3325
Great Elm Group
GEG
$75M
| $20.7K | ﹤0.01% |
11,419
| – | – |
|